Skip to main content
Have a personal or library account? Click to login
The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma Cover

The role of Fluorine-18-Fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma

Open Access
|May 2013

References

  1. 1. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.2009;1531-43.
  2. 2. Ritter J, Bielack SS. Osteosarcoma.2010;320-5.
  3. 3. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence.1999;342-52.
  4. 4. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.2002;776-90.
  5. 5. Bielack S, Jürgens H, Jundt G, Kevric M, Kühne T, Reichardt P, et al. Osteosarcoma: the COSS experience.2009;289-308.
  6. 6. Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, et al. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions.2008;415-20.
  7. 7. Bielack SS, Carrle D, Hardes J, Schuck A, Paulussen M. Bone tumors in adolescents and young adults.2008;67-80.
  8. 8. Messerschmitt PJ, Garcia RM, Abdul-Karim FW, Greenfield EM, Getty PJ. Osteosarcoma2009;515-27.
  9. 9. Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Cooperative German-Austrian-Swiss Osteosarcoma Study Group. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.2003;2011-8.
  10. 10. Posthuma De Boer J, Witlox MA, Kaspers GJ, van Royen BJ. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.2011;493-503.
  11. 11. Kim DH, Kim SY, Lee HJ, Song BS, Kim DH, Cho JB, et al. Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience.2011;170-5.
  12. 12. Wuisman P, Enneking WF. Prognosis for patients who have osteosarcoma with skip metastasis.1990;60-8.
  13. 13. Xu J, Shen J, Ding Y, Shen HY, Zeng ZP, Ma RF, et al. The clinical value of combined use of MR imaging and multi-slice spiral CT in limb salvage surgery for orthopaedic oncology patients: initial experience in nine patients.2012;189-97.
  14. 14. Chen J, Zhao Y, Li X, Sun P, Wang M, Wang R, et al. Imaging primary prostate cancer with 11C-Choline PET-CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.2012;179-88.
  15. 15. Kim JS, Jeong YJ, Sohn MH, Jeong HJ, Lim ST, Kim DW, et al. Usefulness of F-18 FDG PET/CT in subcutaneous panniculitis-like T cell lymphoma: disease extent and treatment response evaluation.2012;279-83.
  16. 16. Lakkaraju A, Patel CN, Bradley KM, Scarsbrook AF. PET/CT in primary musculoskeletal tumours: a step forward.2010; 202959-72.
  17. 17. Treglia G, Cason E, Fagioli G. Recent applications of nuclear medicine in diagnostics (first part).. 2010;84-91.
  18. 18. Treglia G, Salsano M, Stefanelli A, Mattoli MV, Giordano A, Bonomo L. Diagnostic accuracy of 18F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.2012;249-56.
  19. 19. Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET.2000;1695-701.
  20. 20. Kneisl JS, Patt JC, Johnson JC, Zuger JH. Is PET useful in detecting occult nonpulmonary metastases in pediatric bone sarcomas?2006;101-4.
  21. 21. Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.2009;1944-51.
  22. 22. Fuglø HM, Jørgensen SM, Loft A, Hovgaard D, Petersen MM. The diagnostic and prognostic value of 18F-FDG PET/CT in the initial assessment of highgrade bone and soft-tissue sarcoma. A retrospective study of 89 patients.2012;1416-24.
  23. 23. Garcia R, Kim EE, Wong FC, Korkmaz M, Wong WH, Yang DJ, et al. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.1996;1476-9.
  24. 24. Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.2007;5435-41.
  25. 25. Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE. Bone and softtissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.2007;839-47.
  26. 26. Piperkova E, Mikhaeil M, Mousavi A, Libes R, Viejo-Rullan F, Lin H. Impact of PET and CT in PET/CT studies for staging and evaluating treatment response in bone and soft tissue sarcomas.2009;146-50.
  27. 27. London K, Stege C, Cross S, Onikul E, Graf N, Kaspers G, et al. 18F-FDG PET/ CT compared to conventional imaging modalities in pediatric primary bone tumors.2012;418-30.
  28. 28. Bandopadhyaya GP, Gupta P, Singh A, Shukla J, Rastogi S, Kumar R, et al. (99m)Tc-DMSA (V) in evaluation of osteosarcoma: comparative studies with (18)F-FDG PET/CT in detection of primary and malignant lesions.. 2012;371830
  29. 29. Franzius C, Daldrup-Link HE, Sciuk J, Rummeny EJ, Bielack S, Jürgens H, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.2001;479-86.
  30. 30. Iagaru A, Chawla S, Menendez L, Conti PS. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.2006;795-802.
  31. 31. Cistaro A, Lopci E, Gastaldo L, Fania P, Brach Del Prever A, et al. The role of (18) F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.. 2012;1206-10.
DOI: https://doi.org/10.2478/raon-2013-0017 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 97 - 183
Published on: May 21, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Natale Quartuccio, Giorgio Treglia, Marco Salsano, Maria Vittoria Mattoli, Barbara Muoio, Arnoldo Piccardo, Egesta Lopci, Angelina Cistaro, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.